A diagnosis of fibromyalgia was associated with a negative impact on the evolution of rheumatoid arthritis (RA), leading investigators of a recent study to call for...
Mithu Maheswaranathan, MD Credit: Duke Health Belimumab is an anti-B-cell activating factor (BAFF) monoclonal antibody and biologic therapy commonly used in the treatment of systemic lupus...
The management of dyslipidemia has experienced significant changes in recent decades driven by advances in understanding pathophysiology as well as developments in pharmacological therapies. For decades, statins...
Charlie Strange, MD Credit: MUSC Compared to patients with alpha-1 antitrypsin deficiency (AATD) alone, findings from a recent study suggest patients with AATD with liver and/or...
The 16-week Plants for Joints trial investigated the effects of a multidisciplinary lifestyle intervention in people with RA, as compared to usual care. The intervention was...
Findings from a recent study are calling attention to free thyroxine’s protective effect against renal progression in IgA nephropathy (IgAN), also highlighting its utility in combination...
The exact origin and precursor differentiation route of tissue macrophages remains controversial. At the 2024 congress of EULAR – The European Alliance of Associations for Rheumatology...
Stephanie Faubion, MD, MBA Credit: Mayo Clinic Findings from a recent study suggest chronic kidney disease (CKD) is significantly associated with tooth loss in postmenopausal women,...
Timothy Anderson, MD, MASCredit: UPMC Results of a recent analysis is sounding the alarm on a potential, unforeseen consequence that could arise as a result of...
Credit: National Cancer Institute/Unsplash A self-designed questionnaire in a web-based cross-sectional study was created to evaluate the knowledge, attitudes, and practices toward disease management dynamics in...
Credit: Adobe Stock/vaaseenaa A targeted lifestyle counseling app was shown to improve disease activity among patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and spondyloarthritis (SpA),...
An analysis of the landmark EMPA-Kidney trial underlines the need for urgency when prescribing SGLT2 inhibitors in patients at risk of chronic kidney disease progression, with...